|
Pairwise Least Squares Means comparisons following ANOVA of chloroquine (CQ), monodesethylamodiaquine (MdAQ), Quinine (QN) and Artemisinin (ART) loge-transformed IC50 (nM) between years. |
||||||||||||||||
| MdAQ |
CQ |
QN |
ART |
|||||||||||||
|
|
||||||||||||||||
| year Comparison |
Difference Between Means |
Simultaneous 95% Confidence Limits |
Sig. |
Difference Between Means |
Simultaneous 95% Confidence Limits |
Sig. |
Difference Between Means |
Simultaneous 95% Confidence Limits |
Sig. |
Difference Between Means |
Simultaneous 95% Confidence Limits |
Sig. |
||||
|
|
||||||||||||||||
| 1997 – 2000 |
-1.6 |
-2.3 |
-1.0 |
*** |
0.5 |
-0.4 |
1.4 |
-0.3 |
-0.9 |
0.4 |
-0.5 |
-1.6 |
0.5 |
|||
| 1997 – 2001 |
-1.5 |
-2.2 |
-0.8 |
*** |
-0.1 |
-1.0 |
0.8 |
-0.7 |
-1.3 |
0.0 |
*** |
-0.1 |
-1.2 |
0.9 |
||
| 1997 – 2002 |
-1.4 |
-2.0 |
-0.7 |
*** |
0.3 |
-0.5 |
1.2 |
0.1 |
-0.5 |
0.6 |
-0.1 |
-1.1 |
0.9 |
|||
| 1997 – 2003 |
-1.1 |
-1.7 |
-0.4 |
*** |
0.1 |
-0.7 |
1.0 |
-0.3 |
-0.9 |
0.3 |
-0.6 |
-1.6 |
0.5 |
|||
| 1997 – 2004 |
-0.6 |
-1.2 |
-0.1 |
*** |
0.1 |
-0.6 |
0.9 |
0.1 |
-0.4 |
0.6 |
-0.5 |
-1.6 |
0.5 |
|||
| 2000 – 1997 |
1.6 |
1.0 |
2.3 |
*** |
-0.5 |
-1.4 |
0.4 |
0.3 |
-0.4 |
0.9 |
0.5 |
-0.5 |
1.6 |
|||
| 2000 – 2001 |
0.1 |
-0.6 |
0.8 |
-0.6 |
-1.5 |
0.3 |
-0.4 |
-1.1 |
0.3 |
0.4 |
-0.3 |
1.1 |
||||
| 2000 – 2002 |
0.3 |
-0.4 |
0.9 |
-0.1 |
-0.9 |
0.7 |
0.3 |
-0.3 |
1.0 |
0.4 |
-0.3 |
1.1 |
||||
| 2000 – 2003 |
0.6 |
-0.1 |
1.2 |
-0.3 |
-1.2 |
0.6 |
0.0 |
-0.7 |
0.6 |
-0.1 |
-0.8 |
0.7 |
||||
| 2000 – 2004 |
1.0 |
0.4 |
1.6 |
*** |
-0.3 |
-1.1 |
0.4 |
0.4 |
-0.2 |
1.0 |
0.0 |
-0.7 |
0.7 |
|||
| 2001 – 1997 |
1.5 |
0.8 |
2.2 |
*** |
0.1 |
-0.8 |
1.0 |
0.7 |
0.0 |
1.3 |
*** |
0.1 |
-0.9 |
1.2 |
||
| 2001 – 2000 |
-0.1 |
-0.8 |
0.6 |
0.6 |
-0.3 |
1.5 |
0.4 |
-0.3 |
1.1 |
-0.4 |
-1.1 |
0.3 |
||||
| 2001 – 2002 |
0.2 |
-0.5 |
0.8 |
0.5 |
-0.4 |
1.3 |
0.7 |
0.1 |
1.4 |
*** |
0.0 |
-0.7 |
0.7 |
|||
| 2001 – 2003 |
0.4 |
-0.3 |
1.1 |
0.3 |
-0.6 |
1.2 |
0.4 |
-0.3 |
1.0 |
-0.5 |
-1.2 |
0.3 |
||||
| 2001 – 2004 |
0.9 |
0.3 |
1.5 |
*** |
0.3 |
-0.5 |
1.0 |
0.8 |
0.2 |
1.4 |
*** |
-0.4 |
-1.2 |
0.3 |
||
| 2002 – 1997 |
1.4 |
0.7 |
2.0 |
*** |
-0.3 |
-1.2 |
0.5 |
-0.1 |
-0.6 |
0.5 |
0.1 |
-0.9 |
1.1 |
|||
| 2002 – 2000 |
-0.3 |
-0.9 |
0.4 |
0.1 |
-0.7 |
0.9 |
-0.3 |
-1.0 |
0.3 |
-0.4 |
-1.1 |
0.3 |
||||
| 2002 – 2001 |
-0.2 |
-0.8 |
0.5 |
-0.5 |
-1.3 |
0.4 |
-0.7 |
-1.4 |
-0.1 |
*** |
0.0 |
-0.7 |
0.7 |
|||
| 2002 – 2003 |
0.3 |
-0.4 |
0.9 |
-0.2 |
-1.0 |
0.6 |
-0.4 |
-1.0 |
0.2 |
-0.5 |
-1.1 |
0.2 |
||||
| 2002 – 2004 |
0.7 |
0.2 |
1.3 |
*** |
-0.2 |
-0.9 |
0.5 |
0.0 |
-0.5 |
0.6 |
-0.4 |
-1.1 |
0.2 |
|||
| 2003 – 1997 |
1.1 |
0.4 |
1.7 |
*** |
-0.1 |
-1.0 |
0.7 |
0.3 |
-0.3 |
0.9 |
0.6 |
-0.5 |
1.6 |
|||
| 2003 – 2000 |
-0.6 |
-1.2 |
0.1 |
0.3 |
-0.6 |
1.2 |
0.0 |
-0.6 |
0.7 |
0.1 |
-0.7 |
0.8 |
||||
| 2003 – 2001 |
-0.4 |
-1.1 |
0.3 |
-0.3 |
-1.2 |
0.6 |
-0.4 |
-1.0 |
0.3 |
0.5 |
-0.3 |
1.2 |
||||
| 2003 – 2002 |
-0.3 |
-0.9 |
0.4 |
0.2 |
-0.6 |
1.0 |
0.4 |
-0.2 |
1.0 |
0.5 |
-0.2 |
1.1 |
||||
| 2003 – 2004 |
0.5 |
-0.1 |
1.1 |
0.0 |
-0.8 |
0.7 |
0.4 |
-0.2 |
1.0 |
0.0 |
-0.7 |
0.7 |
||||
| 2004 – 1997 |
0.6 |
0.1 |
1.2 |
*** |
-0.1 |
-0.9 |
0.6 |
-0.1 |
-0.6 |
0.4 |
0.5 |
-0.5 |
1.6 |
|||
| 2004 – 2000 |
-1.0 |
-1.6 |
-0.4 |
*** |
0.3 |
-0.4 |
1.1 |
-0.4 |
-1.0 |
0.2 |
0.0 |
-0.7 |
0.7 |
|||
| 2004 – 2001 |
-0.9 |
-1.5 |
-0.3 |
*** |
-0.3 |
-1.0 |
0.5 |
-0.8 |
-1.4 |
-0.2 |
*** |
0.4 |
-0.3 |
1.2 |
||
| 2004 – 2002 |
-0.7 |
-1.3 |
-0.2 |
*** |
0.2 |
-0.5 |
0.9 |
0.0 |
-0.6 |
0.5 |
0.4 |
-0.2 |
1.1 |
|||
| 2004 – 2003 |
-0.5 |
-1.1 |
0.1 |
0.0 |
-0.7 |
0.8 |
-0.4 |
-1.0 |
0.2 |
0.0 |
-0.7 |
0.7 |
||||
Vaillant and Olliaro Malaria Journal 2007 6:156 doi:10.1186/1475-2875-6-156 |
||||||||||||||||